Health Providers Are Developing AI-Enabled Pathology Tools

Health providers and artificial-intelligence software companies are developing tools that could help pathologists better spot diseases, prioritize critical cases and improve patient outcomes, according to a new research report from Frost & Sullivan. The Food and Drug Administration has yet to approve machine-learning pathology tools for use in patient care, but many pathologists say the day isn't far off. The FDA could put its stamp of approval on the technology in the next few years, said Dr. Liron Pantanowitz, vice...